Cogent Biosciences
COGT
COGT
144 hedge funds and large institutions have $547M invested in Cogent Biosciences in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
+9
Holders Change %
+6.67%
% of All Funds
2.11%
Holding in Top 10
2
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-71.43%
% of All Funds
0.03%
New
36
Increased
61
Reduced
30
Closed
24
Calls
$1.3M
Puts
$652K
Net Calls
+$645K
Net Calls Change
-$20K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$26.6M |
| 2 |
KCM
2
Kynam Capital Management
Princeton,
New Jersey
|
$34.4M |
| 3 |
3
Millennium Management
New York
|
$16.4M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$30.5M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$24.4M |
